
Read More
355 times volume spurt: Pharma stock jumps 17.5% post Q1FY26 results; FIIs ...
The shares of the company saw a spurt in volume by more than 355 times on the BSE....

The shares of the company saw a spurt in volume by more than 355 times on the BSE....

The shares of the company have a PE of 38x, an ROE of 17 per cent and an ROCE of 23 per cent....

The company has a market cap of over Rs 400 crore and the stock is up by 16.67 per cent from its 52-...

The shares of the company have a PE of 12x whereas the industry PE is 36x....

The stock gave multibagger returns of 385 per cent from its 52-week low of Rs 6.27 per share....

The stock is up over 40 per cent from its 52-week low of Rs 148.05 per share....

The company has a market cap of over Rs 1,000 crore and has delivered good profit growth of 19 per c...

The company has a market cap of over Rs 70,000 crore and the stock is up by 24.3 per cent from its 5...

The stock is up 11.15 per cent from its 52-week low of Rs 35.70 per share....

The biosimilars division alongside niche product development represents Aurobindo Pharma's main focu...